With @ patients and one-sided alpha of @ , there would be @ % power to detect an absolute @ % difference in undetectable prostate-specific antigen ( PSA ; @ ng/mL ) rate at @ weeks ( relative risk , @ ) ; this end point was previously strongly correlated with survival .